Skip to main content

Table 2 Stenting data

From: In vivo measurement of stent length by using intravascular ultrasound

  

Lesions (n = 95)

Lesion site (%)

LAD

55 (57.9)

LCX

18 (18.9)

RCA

22 (23.2)

Lesion typea (%)

Low risk

41 (43.2)

Moderate risk

46 (48.4)

High risk

8 (8.4)

Lesion length, mm

 

9.09 (7.0–13.25)

Reference diameter, mm

 

3.13 ± 0.64

Prestent MLD, mm

 

0.82 ± 0.32

Prestent diameter stenosis (%)

 

63.06 ± 14.87

Poststent MLD, mm

 

2.56 ± 0.44

Poststent diameter stenosis (%)

 

10.49 ± 5.50

Drug-eluting stent (%)

 

38 (40)

Bare metal stent (%)

 

57 (60)

Stent diameter, mm (%)

2.5 mm

14 (14.74)

3.0 mm

54 (56.84)

3.5 mm

23 (24.21)

4.0 mm

4 (4.21)

Stent length, mm (%)

8.0 mm

2 (2.1)

9.0 mm

2 (2.1)

12.0 mm

5 (5.3)

13.0 mm

4 (4.2)

15.0 mm

18 (18.9)

18.0 mm

32 (33.7)

20.0 mm

3 (3.2)

23.0 mm

18 (18.9)

24.0 mm

3 (3.2)

25.0 mm

1 (1.1)

28.0 mm

6 (6.3)

30.0 mm

1 (1.1)

Stent strut (wire) thickness, mm

 

0.14 (13.0–16.0)

Stent deployment pressure, atm

 

16.0 (14.0–18.0)

Poststent balloon dilatation (%)

 

19 (20%)

  1. Data are given as mean ± SD, percentage, or median (IQR)
  2. LAD left anterior descending artery, LCX left circumflex artery, MLD minimal lumen diameter, RCA right coronary artery
  3. aAmerican College of Cardiology/American Heart Association (ACC/AHA) classification [10]
  4. p < 0.0001 (compared with the prestent measurements)